KisoTerra Biotech Corp. — Form D

KisoTerra Biotech Corp. of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2020-11-02. The offering totals $210K, of which $210K was reported sold. Industry: Other.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
Kenneth PhilippeExecutive OfficerCHILLIWACK, A1
Josef ReschreiterDirectorVancouver, A1
Josef ReschreiterExecutive OfficerVancouver, A1
Rich FrontainDirectorVancouver, A1
David WorkDirectorVancouver, A1
Michael StockerDirectorVancouver, A1
Michael StockerExecutive OfficerVancouver, A1
Neil BrandaDirectorVancouver, A1
Neil BrandaExecutive OfficerVancouver, A1
Dirk LangeDirectorVancouver, A1
Dirk LangeExecutive OfficerVancouver, A1
Brent HunterExecutive OfficerVancouver, A1
Douglas FrankiwDirectorVancouver, A1
Dave WorkDirectorCHILLIWACK, A1
Dave WorkExecutive OfficerCHILLIWACK, A1
John JohnstonDirectorChicago, IL
John JohnstonExecutive OfficerChicago, IL
Lawrence LundDirectorSmithers, A1
Lawrence LundExecutive OfficerSmithers, A1
Daniel HunterDirectorCHILLIWACK, A1
Daniel HunterExecutive OfficerCHILLIWACK, A1

Other filings by this issuer (6)

FiledFormOfferingSold
2025-02-05D$24K$24K
2025-01-22D$250K$250K
2024-05-30D$10K$10K
2021-07-07D$3.7M$3.7M
2019-03-27D$20K$20K
2018-11-15D$14K$14K

More